Tech & Pharma
Its VereFlu lab-on-a-chip platform has been shown to detect the H7N9 avian flu subtype that is responsible for the recent flu outbreak in China.
Life science provider New England Biolabs has extended its global subsidiary network with the opening of New England Biolabs Pte. Ltd. in Singapore.
Sanofi Pasteur and Xiamen University in China have agreed to jointly develop a universal flu vaccine.
Baxter China has piloted a program to deploy a sustainable care and delivery model for peritoneal dialysis patients living in rural areas of the country.
Astellas Pharma Inc. on Thursday entered into a collaboration with Ambrx Inc. for the discovery and development of novel antibody drug conjugates.
Researchers in Japan have developed a new system that detects autism in infants using small fluctuations in eye movement.
Takeda Pharma has submitted New Drug Applications for cell culture-based H5N1 influenza vaccines to the Ministry of Health, Labor and Welfare in Japan.
H3 Biomedicine Inc. and BGI have entered into a partnership to sequence and publish genomic data from pre-clinical cancer models.
Sanofi announced on Friday the official launch of a construction project for a new manufacturing facility in Ho Chi Minh City.
Singapore’s A*STAR and Fujitsu Limited will explore the creation of the first Center of Excellence for computational social science and engineering in Singapore.